News
4h
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...
The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...
In recent interviews, Health and Human Services Secretary Robert F. Kennedy Jr. has minimized the risk COVID-19 poses to kids ...
While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...
The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.
There also was no link between miscarriage risk and the number of vaccinations a woman had gotten, or whether she’d gotten ...
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
A new study links growing vaccine skepticism to pet care. Lollypop Farm offers free rabies shots, food and vet access for dogs and cats in Rochester.
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government ... Kennedy Jr. has cast doubt on the safety of mRNA vaccines, but Moderna ...
Early COVID suppression could have prevented 180,000 UK deaths, study reveals … FDA, CDC pause chikungunya vaccine for adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results